Heidelberg Pharma AG (ETR:HPHA) | Finanzwire

Basculer en Français

10035	Companies
204299	Keywords
134632	Articles
108355	Press releases

Home
Companies
Heidelberg Pharma AG

BRIEF

published on 03/19/2024 at 09:52, 1 year 11 months ago

Heidelberg Pharma Receives Upfront Payment from HealthCare Royalty Agreement

Heidelberg Pharma HealthCare Royalty Zircaix Antibody Drug Conjugates Biotech Funding
PRESS RELEASE

published on 03/19/2024 at 09:47, 1 year 11 months ago

Heidelberg Pharma announces receipt of non-refundable upfront cash payment following the successful closing of its royalty purchase agreement with HealthCare Royalty
Heidelberg Pharma receives USD 25 million upfront cash payment from HealthCare Royalty for royalty purchase agreement. Funds to advance ADC pipeline development and extend cash runway

Heidelberg Pharma HealthCare Royalty ADC Pipeline Royalty Purchase Agreement Cash Payment
BRIEF

published on 03/18/2024 at 07:30, 1 year 11 months ago

Heidelberg Pharma Advances to Cohort 6 in Multiple Myeloma Study with HDP-101

Heidelberg Pharma HDP-101 Multiple Myeloma Phase I/IIa Study Cohort 6
PRESS RELEASE

published on 03/18/2024 at 07:25, 1 year 11 months ago

Heidelberg Pharma announces progress into Cohort 6 with its proprietary ATAC candidate HDP-101 in Phase I/IIa multiple myeloma study
Heidelberg Pharma progresses into Cohort 6 with ATAC candidate HDP-101 in Phase I/IIa multiple myeloma study, showing first objective responses and partial remissions. Amended protocol includes optimized dosing regimens

Heidelberg Pharma Multiple Myeloma Phase I/IIa Study ATAC Candidate Protocol Amendment
BRIEF

published on 03/06/2024 at 07:51, 2 years ago

Heidelberg Pharma to Showcase HDP-101 Efficacy and ADC Technology at AACR 2024

Cancer Research Heidelberg Pharma HDP-101 ADC Technology AACR Meeting 2024
PRESS RELEASE

published on 03/06/2024 at 07:46, 2 years ago

Heidelberg Pharma to Present First Efficacy Data on HDP-101 and Data from Proprietary ADC Technology Platform at AACR Meeting 2024
Heidelberg Pharma to present first efficacy data on HDP-101 and data from proprietary ADC technology platform at AACR Meeting 2024. Details of ATAC and ADC-based cancer therapies

Clinical Trials Heidelberg Pharma ADC Technology AACR Meeting 2024 ATAC Therapies
BRIEF

published on 03/04/2024 at 11:24, 2 years ago

Heidelberg Pharma Secures Up to $115 Million in Royalty Financing from HealthCare Royalty

Biopharmaceuticals Heidelberg Pharma HealthCare Royalty Royalty Financing ZircaixTM
PRESS RELEASE

published on 03/04/2024 at 11:19, 2 years ago

Heidelberg Pharma Announces Royalty Financing Agreement with HealthCare Royalty for up to USD 115 million
Heidelberg Pharma announces royalty financing agreement with HealthCare Royalty for up to USD 115 million. Agreement to purchase royalties from Telix Pharmaceuticals for Zircaix(TM)

Biotech Heidelberg Pharma HealthCare Royalty Royalty Financing Zircaix
BRIEF

published on 03/04/2024 at 11:07, 2 years ago

Heidelberg Pharma Secures Royalty Financing Deal Worth Up to $115 Million with HealthCare Royalty

Oncology Heidelberg Pharma HealthCare Royalty Royalty Financing Zircaix
PRESS RELEASE

published on 03/04/2024 at 11:02, 2 years ago

EQS-Adhoc: Heidelberg Pharma Announces Royalty Financing Agreement with HealthCare Royalty for up to USD 115 million
Heidelberg Pharma announces royalty financing agreement with HealthCare Royalty for up to USD 115 million. Agreement involves royalties from worldwide sales of Telix Pharmaceuticals' ZircaixTM

Heidelberg Pharma HealthCare Royalty Royalty Financing Telix Pharmaceuticals ZircaixTM

Accesswire

Published on 03/16/2026 at 11:30, 1 minute ago

Relevant Gold Announces $15 Million Strategic Financing with Participation from Kinross, Bollinger, and McEwen
Published on 03/16/2026 at 11:00, 31 minutes ago

Vox Royalty Announces Inclusion in MVIS(R) Global Junior Gold Miners Index and VanEck Junior Gold Miners ETF (GDXJ)
Published on 03/16/2026 at 11:00, 31 minutes ago

Banyan Intercepts Several New Distinct High-grade Silver Veins, including 3,408 g/t Ag over 1.4 m, at AurMac, Yukon
Published on 03/15/2026 at 23:25, 12 hours 6 minutes ago

Tunkillia 'Phase 2' Resource Upgrade Drilling Begins
Published on 03/15/2026 at 18:00, 17 hours 31 minutes ago

SEG Announced 2025 Annual Results Initiating First Special Dividend Distribution Payout Ratio Reached 88% Newly Signed Orders Exceeded RMB100-Billion Mark for the Second Consecutive Year

View all ACCESSWIRE

EQS Group

Published on 03/16/2026 at 11:00, 31 minutes ago

BIO-Europe Spring® 2026: Partnering Momentum Builds as Global Biopharma Leaders Set Course for Lisbon
Published on 03/16/2026 at 11:00, 31 minutes ago

CTS EVENTIM: EVENTIM LIVE expands in the French live market with promoter Pierre-Alexandre Vertadier
Published on 03/16/2026 at 11:00, 31 minutes ago

Vossloh to deliver high-speed grinding train to China
Published on 03/16/2026 at 11:00, 31 minutes ago

Nebius signs new AI infrastructure agreement with Meta
Published on 03/16/2026 at 10:45, 46 minutes ago

HKTDC Smart Lighting Expo and Hong Kong International Lighting Fair (Spring Edition) to open in April

Les Echos

Published on 03/16/2026 at 08:30, 3 hours 1 minute ago

CDA - Update on CDA' parks solarization program
Published on 03/13/2026 at 19:50, 2 days 15 hours ago

Availability of ENGIE’S 2025 Universal Registration Document
Published on 03/13/2026 at 18:05, 2 days 17 hours ago

Availability of the 2025 Universal Registration Document of OPmobility SE
Published on 03/13/2026 at 07:30, 3 days 4 hours ago

BIOPHYTIS PRESENTS ITS DEVELOPMENT PROGRAMS IN OBESITY AND SARCOPENIA AT THE ICFSR CONFERENCE
Published on 03/12/2026 at 18:00, 3 days 17 hours ago

NEW OR RENEWED AGREEMENTS BETWEEN EURAZEO AND CERTAIN FAMILY SHAREHOLDERS

View all LES ECHOS COMFI WIRE